Shares of Bio-Path Holdings
BPTH,
fell late Thursday after the company said it had reached a deal for an at-the-market share offering.
The stock was down 6.3%, to $4.03, in after-hours trading, following a 0.1% drop in the regular session. Shares are down about 54% in the last year.
The Houston-based biotechnology company said in a regulatory filing that H.C. Wainwright had agreed to be the sales agent. The at-the-market offering will be for up to $2 million worth of stock.
Bio-Path will pay Wainwright a commission of 3% of the total gross proceeds.
This post was originally published on Market Watch
